US pharma tariffs pose limited immediate threat, but risks loom for India As the US targets branded drug imports, Indian pharma leaders are raising questions about both immediate shocks and long-term strategy.

As the US targets branded drug imports, Indian pharma leaders are raising questions about both immediate shocks and long-term strategy.

#USpharmatariffs #pharma #WealthMillsSecurities #BajajHealthcare #pharmaceuticalimports